House Antitrust Task Force To Hold Hearing on Sirius/XM Merger
Client Alert | 1 min read | 02.19.07
Following the announcement by Sirius Satellite Radio Inc. and XM Satellite Radio Holdings Inc.'s announcement on Monday, February 19, 2007 of its plans for a $13 billion "merger of equals," the U.S. House of Representatives' Judiciary Committee announced on February 21 that its newly formed Antitrust Task Force will hold a hearing next week on Wednesday, February 28, 2007 at 3:00 p.m. to investigate the potential anticompetitive effects of the proposed merger. Sirius and XM are currently the only two companies licensed to offer satellite radio to U.S. consumers, thereby raising antitrust concerns. The two satellite radio companies, however, have argued that satellite radio faces tremendous competition from all other types of music delivery services, including mp3 players, iPods, and, of course, terrestrial radio.
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
